BlackRock Investment Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

BlackRock Investment Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-94,410	Closed	-$3.89M	–	4224
2015 Q2	$3.89M	Buy	94,410 +12,282	+15%	+$440K	﹤0.01%	1699
2015 Q1	$2.89M	Buy	82,128 +901	+1%	+$30.5K	﹤0.01%	1774
2014 Q4	$2.61M	Sell	81,227 -745	-0.9%	-$21.5K	﹤0.01%	1837
2014 Q3	$2.3M	Buy	81,972 +263	+0.3%	+$8.01K	﹤0.01%	1900
2014 Q2	$2.47M	Buy	81,709 +298	+0.4%	+$8.23K	﹤0.01%	1918
2014 Q1	$2.25M	Buy	81,411 +636	+0.8%	+$16.6K	﹤0.01%	1957
2013 Q4	$2.06M	Sell	80,775 -1,130	-1%	-$34.8K	﹤0.01%	2009
2013 Q3	$2.45M	Buy	81,905 +4,022	+5%	+$112K	﹤0.01%	1808
2013 Q2	$2.24M	Buy	+77,883	New	+$2.15M	﹤0.01%	1778

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

BlackRock Investment Management's BRLI Position: Q3 2015 in Review

BlackRock Investment Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 94,410 shares — an estimated $3.89M sold.

BlackRock Investment Management first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $3.89M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

BlackRock Investment Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
BlackRock Investment Management sold 94,410 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $3.89M.
BlackRock Investment Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
BlackRock Investment Management's BIO-REFERENCE LABS INC-NEW- position peaked at $3.89M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on BlackRock Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.